findinEsegui ricerca

Launch of ENTENTE

The first European network to boost knowledge transfer activity in health research in academic and governmental organisations and industry-academia collaboration.

September 19th, 2012, Paris (France) - The ENTENTE project was officially launched September 12th in Paris, France. ENTENTE is a coordinated action funded by the European Commission under the Health Work Programme of the 7th Framework Programme. This consortium brings together seven partners specialised in knowledge transfer from France, The United Kingdom, Belgium, and The Netherlands.

The objective of this 3-year project is to reinforce knowledge transfer offices in universities, public research organisations (PROs), hospitals and to promote industry-academia trans-national collaboration in the health sector.

The project will focus on:
  • developing a web platform for shared learning and networking for scientists, hospitals, programme managers and policy makers, enabling a continuous update of innovative measures and an interactive networking among all type of actors.
  • identifying and promoting good knowledge management, knowledge transfer practices and give visibility to the best achievements at the European level, including tax incentives.
  • structuring and implementing a TTO professional exchange programme allowing staff exchanges between different types of actors, for instance TTO to pharmaceutical industry.
  • promoting interaction between universities, industry, investors and individual researchers through the organisation of workshops, partnering events and disseminating at national level conclusions, best practices and discussions.
To achieve these goals, the partners will rely on three advisory groups encompassing all the actors of the knowledge transfer in the health sector.
  • The first advisory group will engage Technology Transfer Offices through their senior directors/CEO.
  • The second advisory group will bring Industry and Healthcare stakeholders, from the pharmaceutical industry but also from Venture Capital and Investor Relations associations as well as Biotech/SMEs associations, and healthcare sector.
  • The third advisory group will consist of Universities associations like LERU, PROs associations like Science Europe, as well as individual PROs such as Inserm and ISCIII (Institute of Health Carlos III).
Advisory groups will actively participate to the various activities by attending meetings to provide their input, participate to networking and disseminating activities, as well as to the staff exchange programme. A maximum of three workshops per year are foreseen, that will be placed at the occasion of partner’s events like the TTS Europe, ProTon Europe and ASTP meetings.
Moreover, the project leaders will actively complement and produce synergies with already existing EU-projects or initiatives like Proinno Europe or advisory bodies like the working group on knowledge transfer from ERAC (European research area committee) or the European Enterprise Network (EEN) who will be consulted for benchmarking on existing tools, best practices and policy recommendations at EU level.
“The main result of our project will be the creation of a steady pan-European knowledge transfer community gathering all the actors in Health, including universities, SMEs, PROs and Industry as well as investors and tech transfer professionals. These exchanges will be mostly cross-border, which will create new business development. The end result is to go towards an improvement of the global European knowledge transfer in Health.” concludes Karine Baudin, coordinator of Entente.
Entente website :
Press contact
Céline Cortot - Inserm Transfert (France)
More about Entente
HEALTH.2012.4.1-1: Network to encourage knowledge transfer activity in FP-funded health research (especially in academic and governmental organisations)
Contact Karine Baudin, PhD - Inserm Transfert (France)
Coordinator - Entente
Phone : +33 1 55 03 01 22
Founded in 2000, Inserm Transfert SA is the private subsidiary of the French National Institute of the Health and Medical Research (Inserm), dedicated to technology transfer (from invention disclosure to industrial partnership). Inserm Transfert manages European and International research projects, supports large scale projects in epidemiology and public health. Since 2009, Inserm Transfert has run a proof of concept fund. The company is also committed to seed financing in the biotech sector, through its dedicated seed fund company Inserm Transfert Initiative.
The initiative of a multinational group of professionals to meet and share experiences on a regular basis resulted in the establishment of the non-profit Association of European Science & Technology Transfer Professionals. ASTP is practitioners and members focused and is growing. Our association consists of more than 600 individual members, covering 43 countries. The majority of our members are technology transfer/knowledge transfer professionals at public knowledge institutions. Our mission is to professionalise and promote technology and knowledge transfer between the European science base and industry.
TTS Ltd runs the TTS Global Initiative, the leading international community and network of experts and key practitioners in healthcare technology transfer, innovation, licensing, partnering, IPR, venture capital and finance. This includes the leading experts and practitioners from research, tech transfer, IP, entrepreneurs, SMEs, venture capital, pharma and industry licensing, business development, corporate finance, patients organizations, foundations, funding agencies, and other key stakeholders, to work directly and collaboratively in an open round-table discursive format to educate, train and build the competence and capacity of young tech transfer officers and developing tech transfer offices. The TTS Global Initiative serves as an instrumental platform in networking the various experts in bringing healthcare innovation to market and to patients. Many of the world’s leading research institute, university and clinic TTOs are active members and participants, as are most big pharma, large biotech, and key healthcare venture capital investors.
Proton Europe
Proton Europe is the paneuropean association of tech transfer offices from public research, mainly academic research. Grounded in 2003 with the support of the EU, ProTon is the European linkage between national associations of tech transfer in Europe, supplying support and information to the EU about academic tech transfer. With about 250 university members, Proton has databases of good practices and has large experience in staff exchange programmes.
University of Liege – Interface Entreprises-University
The Interface Entreprises-University of Liege has been set up in 1989, with the aim to promote cooperative research, and to manage the technology transfer for the University and the university hospital. With a team of about 40 experienced people, Interface provides now support to scientists for patenting, for proof of concept, market studies, licensing, spin offing, but also for knowledge exchange by managing the Liege Science Park. More than 50% of the activity is focused on biotechnology and health, especially within the 100 spin off companies grounded.
KULeuven Research & Development (LRD) was established in 1972 as one of the first technology transfer offices in Europe and has a long tradition in collaboration with industry, patenting, licensing and spin-off creation. LRD is dedicated to building bridges between science and industry and to transferring knowledge and technologies to the marketplace.
LRD’s multidisciplinary team of over 70 people includes legal counsellors, IPR officers, business development managers and a specialized financial and administrative staff incorporating EU Framework Programme advisors. The team guides both researchers and companies through all aspects of the technology transfer process.
The prominent position of the university hospital within the KULeuven brought about a particular interest in medical and health related research. In consequence, LRD has acquired relevant expertise and dedicates substantial resources towards technology transfer activities within these fields. In 2008, LRD was awarded the IPTEC Tech Transfer Award in Frankfurt. This international award recognizes institutions with an outstanding record in technology transfer: making the bridge between science and industry, and getting technologies to the market.
VIB is a life sciences research institute in Flanders, Belgium. With more than 1200 scientists from over 60 countries, we perform basic research into the molecular foundations of life. VIB works in close partnership with four universities – UGent, KULeuven, University of Antwerp and Vrije Universiteit Brussel and is funded by the Flemish government. VIB is an excellence-based entrepreneurial institute that focuses on translating basic scientific results into pharmaceutical, agricultural and industrial applications, and plays a role as catalyst in the establishment and growth of biotech clusters.
VIB has a team of 15 persons with a lot of experience from industry, fully dedicated to technology transfer. The team has expertise in intellectual property rights, deal negotiation, European contracts, licensing, establishing spin-off companies, start-up and venture financing and has a very large network in the academic, industrial, governmental and investor community. The team further operates a proof-of-concept fund, a seed money fund and an incubator fund.
Health and medical related research have a dominant position within the activities of VIB. This is illustrated by the fact that at present VIB’s licensees and start-up companies are jointly marketing 6 diagnostics and have 14 candidate drugs in clinical development, which all originated from VIB research. In addition, VIB’s department in plant biotechnology is a world-leader in Plant Science and its research formed the basis for 2 spin-off companies and different partnerships with large crop production companies. is an independent media agency promoting leading-edge European innovation via TV media and the web. designs and implements communication strategies for large research organisations and EU-funded projects and is able to establish permanent links between research communities and the media. The web platform, launched in 2005, is today a primary information source for European science and technology. is a European Economic Interest Group (EEIG) based in Brussels with offices in Italy, Germany and France.
This project has received funding from the European Union’s Seventh Programme for 
research, technological development and demonstration under grant agreement No 305128
  ENTENTE is supported by the European Commission and coordinated by Inserm-Transfert SA